Atossa Therapeutics, Inc. ATOS
2.13 USD 0.00 (+0.00%)
Nov 10, 2026, 12:10 PM EST
2.12 Day range 2.31
1.70 52-week range 14.85
- YTD
- -75.93%
- 1 year
- -83.10%
News
benzinga.com Atossa Therapeutics Q3 EPS $(0.56) Beats $(0.90) Estimate Atossa Therapeutics (NASDAQ:ATOS) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.90) by 37.08 percent. This is a 60 percent decrease over losses of…
prnewswire.com Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other…
benzinga.com Atossa Therapeutics Confirms Shares To Begin Trading With One Stapled Contingent Value Right As Of Close Of Business On October 19 Under the terms of the Stapled Contingent Value Rights Agreement (the "CVR Agreement") with VStock Transfer, LLC, as rights agent, each share of Atossa common stock outstanding at the close of…
benzinga.com Atossa Therapeutics Inks Stapled Contingent Value Rights Agreement With VStock Transfer; Atossa Declares Dividend Of One Stapled CVR For Each Share Of Atossa Common Stock Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines in oncology and other areas of significant unmet need,
benzinga.com Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $25 Ascendiant Capital analyst Edward Woo maintains Atossa Therapeutics (NASDAQ:ATOS) with a Buy and raises the price target from $24 to $25.
benzinga.com Atossa Therapeutics Q2 EPS $(0.95) Beats $(1.02) Estimate Atossa Therapeutics (NASDAQ:ATOS) reported quarterly losses of $(0.95) per share which beat the analyst consensus estimate of $(1.02) by 6.86 percent. This is a 171.43 percent decrease over losses of…
benzinga.com Atossa Therapeutics Announces npj Breast Cancer Publication Highlighting Novel Endoxifen-Based Compounds In ESR1-Mutant Breast Cancer Models Peer-reviewed preclinical study published in npj Breast Cancer identifies new chemical entities with activity in ESR1-mutant modelsFindings suggest potential for combination with abemaciclibSEATTLE,…- benzinga.com Atossa Therapeutics Presents Mechanism-Driven (Z)-Endoxifen Data In McCune-Albright Syndrome At 2026 AACR Special Conference In Cancer Research Preclinical Data Poster Highlights Dual Estrogen Receptor and PKC-β/AKT Pathway Modulation as a Potential Therapeutic Strategy for Estrogen-Driven Pathology in McCune-Albright syndromeSEATTLE, July…
- benzinga.com Rodman & Renshaw Initiates Coverage On Atossa Therapeutics with Buy Rating, Announces Price Target of $12 Rodman & Renshaw analyst Michael G. King Jr. initiates coverage on Atossa Therapeutics (NASDAQ:ATOS) with a Buy rating and announces Price Target of $12.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session 
benzinga.com Crude Oil Edges Higher; Driven Brands Posts Upbeat Earnings US stocks rise with Nasdaq up 150 points. Dow up 0.54%, Nasdaq up 0.63%, S&P 500 up 0.26%. Industrials and Enliven Therapeutics lead gains. Dana Inc and Oracle Corp down. Oil up 0.7%, gold down 0.7%.…
benzinga.com Dow Jumps Over 250 Points; US Initial Jobless Claims Rise US stocks up, Dow gains 250 pts. Dow up 0.58% while NASDAQ up 0.67%. Materials shares jump 1.5%, communication services down 1.3%. Jobless claims up.- benzinga.com Atossa Therapeutics Enters Securities Purchase Agreement With Institutional Investors For 1,363,638 Shares Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need,…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com Atossa Therapeutics Announces Acceptance Of (Z)-Endoxifen DMD Manuscript For Publication In Degenerative Neurological And Neuromuscular Disease Review article accepted for publication in Degenerative Neurological and Neuromuscular Disease and builds on Atossa's previously published Duchenne Muscular Dystrophy (DMD) researchSEATTLE, May 20,…
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session 
benzinga.com This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - benzinga.com Earnings Scheduled For March 25, 2025
- benzinga.com Earnings Scheduled For August 14, 2023 Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 258 companies hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 297 companies reached new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 241 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 167 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's session, 49 companies made new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Monday Monday saw 825 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 1076 companies hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 340 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 215 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 540 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 1043 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 431 companies hit new 52-week lows.
- benzinga.com 64 Biggest Movers From Yesterday Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares climbed 128.8% to settle at $9.06 on Tuesday.
- benzinga.com Stocks That Hit 52-Week Highs On Friday This morning 143 companies set new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Thursday Before 10 a.m. ET on Thursday, 145 companies set new 52-week highs.
- benzinga.com 62 Biggest Movers From Yesterday Gainers
- benzinga.com Stocks That Hit 52-Week Highs On Tuesday Tuesday morning saw 244 companies set new 52-week highs.
- benzinga.com 60 Biggest Movers From Yesterday Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares surged 87.3% to close at $9.14 on Monday on abnormally-high session volume.
- benzinga.com Stocks That Hit 52-Week Highs On Monday Before 10 a.m. ET Monday, 296 stocks made new 52-week highs.
- benzinga.com 70 Biggest Movers From Friday Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday.
- benzinga.com 101 Biggest Movers From Friday Gainers Atlantic American Corporation. (NASDAQ: AAME) shares surged 117.6% to close at $5.20 on Friday after surging over 5% on Thursday.
- benzinga.com 66 Stocks Moving In Friday's Mid-Day Session Gainers Atlantic American Corporation. (NASDAQ: AAME) shares jumped 279.5% to $9.07 after surging over 5% on Thursday.
- benzinga.com 36 Stocks Moving in Wednesday's Pre-Market Session Gainers 10X Capital Venture Acquisition Corp (NASDAQ: VCVC) shares rose 54.5% to $16.90 in pre-market trading. REE Automotive will go public through a merger with 10X Capital Venture Acquisition…
- benzinga.com 101 Biggest Movers From Yesterday Gainers New Concept Energy, Inc. (NYSE: GBR) shares jumped 959.3% to close at $25.00 on Thursday.
- benzinga.com 70 Stocks Moving In Thursday's Mid-Day Session Gainers JanOne Inc. (NYSE: JAN) shares jumped 175.5% to $26.25 amid continued momentum driven by retail investor interest in the stock.
- benzinga.com 45 Stocks Moving in Thursday's Pre-Market Session Gainers JanOne Inc. (NASDAQ: JAN) shares rose 154.8% to $24.26 in pre-market trading after climbing around 48% on Wednesday.
- benzinga.com 70 Biggest Movers From Yesterday Gainers Greenwich Lifesciences Inc (NASDAQ: GLSI) shares jumped 998.1% to close at $57.10 on Wednesday after the company reported data showing 0% breast cancer recurrences following surgery and…
- benzinga.com 38 Stocks Moving in Thursday's Pre-Market Session Gainers Orbital Energy Group, Inc. (NASDAQ: OEG) shares rose 132.3% to $1.94 in pre-market trading after surging more than 36% on Wednesday.
benzinga.com Stocks That Hit 52-Week Highs On Monday On Monday, 270 companies set new 52-week highs.